The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Chemomab Therapeutics Ltd(NASDAQ:CMMB)


Chemomab Therapeutics Ltd. engages in the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 16, 2021. Chemomab Therapeutics Ltd...
Share this website to your friends
Chemomab Therapeutics Days Payable Outstanding ttm (DPO)
Chemomab Therapeutics Days Inventory Outstanding ttm (DIO)
Chemomab Therapeutics Op Cashflow Per Share ttm
Chemomab Therapeutics Free Cashflow Per Share ttm
Chemomab Therapeutics Cash Per Share ttm
Chemomab Therapeutics (GAAP) P/E ratio ttm
Chemomab Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.